CS for House Bill No. 96(HSS) Summary

• Amends AS 08.80.157(h) to allow wholesale drug distributors to dispense dialysate drugs and devices directly to patients with end-stage renal disease for home dialysis, with specific conditions and safeguards.

• Requires drugs and devices be approved by the FDA, delivered in original sealed packaging only upon physician's order, and limited to dialysates composed solely of fluids, electrolytes, and sugars.

• Mandates wholesale drug distributors implement bar code scanning and verification systems to confirm dialysate drugs or devices match patient-specific orders and labels, plus additional secondary accuracy and delivery checks.

• Requires a licensed pharmacist consultant to conduct monthly retrospective audits of 10 percent of dialysate orders and perform assessments at least twice monthly to ensure quality of product storage, handling, and distribution.

• Takes effect May 7, 2023.